CCn1c2c(c(=O)n3ncc(C(=O)N4CCN(c5ccccc5)CC4)c13)CN(Cc1ccc(OC)cc1)CC2
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?